# Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer

> **NCT02841228** · PHASE2 · UNKNOWN · sponsor: **Hunan Province Tumor Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** IMRT + SIB + Chemotherapy

## Key facts

- **NCT ID:** NCT02841228
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2018-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02841228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02841228, "Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02841228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*